Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ACETYLCYSTEINE
(1963)
Small molecule
Glutathione precursor
INHALATION; INTRAVENOUS; ORAL
Approved
Chemical and Drug Induced Liver Injury; Cystic Fibrosis; Eye Diseases; Wounds and Injuries
ACETYLCYSTEINE
×
Maximum Phase:
4
First Approval:
1963
UNII:
WYQ7N0BPYC
Molecule Type:
Small molecule
Molecular Formula:
C5H9NO3S
Molecular Weight:
163.2
AlogP:
-0.49
PSA:
66.4
HBD:
3.0
HBA:
#RotB:
3.0
Source:
IDOXURIDINE
(1963)
Small molecule
DNA inhibitor
OPHTHALMIC
Approved
Eye Infections; Virus Diseases
IDOXURIDINE
×
Maximum Phase:
4
First Approval:
1963
UNII:
LGP81V5245
Molecule Type:
Small molecule
Molecular Formula:
C9H11IN2O5
Molecular Weight:
354.1
AlogP:
-1.22
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FLUOCINOLONE ACETONIDE
(1963)
Small molecule
Glucocorticoid receptor agonist
INTRAVITREAL; OTIC; TOPICAL
Approved
Dermatitis, Atopic; Dermatitis, Seborrheic; Eye Diseases; Hemorrhoids; Infections; Macular Edema; Melanosis; Psoriasis; Skin Diseases; Uveitis
FLUOCINOLONE ACETONIDE
×
Maximum Phase:
4
First Approval:
1963
UNII:
0CD5FD6S2M
Molecule Type:
Small molecule
Molecular Formula:
C24H30F2O6
Molecular Weight:
452.49
AlogP:
2.37
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
2.0
Source:
OXANDROLONE
(1964)
Small molecule
Androgen Receptor agonist
ORAL
Approved
Unknown
OXANDROLONE
×
Maximum Phase:
4
First Approval:
1964
UNII:
7H6TM3CT4L
Molecule Type:
Small molecule
Molecular Formula:
C19H30O3
Molecular Weight:
306.45
AlogP:
3.54
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
0.0
Source:
NALIDIXIC ACID
(1964)
Small molecule
Bacterial DNA gyrase inhibitor
ORAL
Approved
Bacterial Infections
NALIDIXIC ACID
×
Maximum Phase:
4
First Approval:
1964
UNII:
3B91HWA56M
Molecule Type:
Small molecule
Molecular Formula:
C12H12N2O3
Molecular Weight:
232.24
AlogP:
1.42
PSA:
72.19
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PRALIDOXIME CHLORIDE
(1964)
Small molecule
Acetylcholinesterase activator
INJECTION; ORAL
Approved
Myasthenia Gravis; Poisoning
PRALIDOXIME CHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
38X7XS076H
Molecule Type:
Small molecule
Molecular Formula:
C7H9ClN2O
Molecular Weight:
172.61
AlogP:
0.32
PSA:
36.47
HBD:
1.0
HBA:
#RotB:
1.0
Source:
LINCOMYCIN
(1964)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections; Multiple Sclerosis
LINCOMYCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
BOD072YW0F
Molecule Type:
Small molecule
Molecular Formula:
C18H34N2O6S
Molecular Weight:
406.55
AlogP:
-0.86
PSA:
122.49
HBD:
5.0
HBA:
#RotB:
7.0
Source:
NORTRIPTYLINE
(1964)
Small molecule
Unknown
Unknown
Metabolites
Depressive Disorder
NORTRIPTYLINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
BL03SY4LXB
Molecule Type:
Small molecule
Molecular Formula:
C19H21N
Molecular Weight:
263.38
AlogP:
3.83
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LINCOMYCIN HYDROCHLORIDE
(1964)
Small molecule
70S ribosome inhibitor
INJECTION; ORAL
Approved
Enterocolitis, Pseudomembranous; Infections
LINCOMYCIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
M6T05Z2B68
Molecule Type:
Small molecule
Molecular Formula:
C18H37ClN2O7S
Molecular Weight:
461.02
AlogP:
-0.86
PSA:
122.49
HBD:
5.0
HBA:
#RotB:
7.0
Source:
MELPHALAN
(1964)
Small molecule
DNA inhibitor
ORAL
Approved
Carcinoma; Multiple Myeloma; Neoplasms
MELPHALAN
×
Maximum Phase:
4
First Approval:
1964
UNII:
Q41OR9510P
Molecule Type:
Small molecule
Molecular Formula:
C13H18Cl2N2O2
Molecular Weight:
305.21
AlogP:
1.93
PSA:
66.56
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AMINOCAPROIC ACID
(1964)
Small molecule
Plasminogen inhibitor
INJECTION; ORAL
Approved
Hemorrhage
AMINOCAPROIC ACID
×
Maximum Phase:
4
First Approval:
1964
UNII:
U6F3787206
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO2
Molecular Weight:
131.18
AlogP:
0.59
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PRALIDOXIME
(1964)
Small molecule
Unknown
Unknown
Approved
Unknown
PRALIDOXIME
×
Maximum Phase:
4
First Approval:
1964
UNII:
P7MU9UTP52
Molecule Type:
Small molecule
Molecular Formula:
C7H9N2O+
Molecular Weight:
137.16
AlogP:
0.32
PSA:
36.47
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ACETOHEXAMIDE
(1964)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus
ACETOHEXAMIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
QGC8W08I6I
Molecule Type:
Small molecule
Molecular Formula:
C15H20N2O4S
Molecular Weight:
324.4
AlogP:
2.21
PSA:
92.34
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NOVOBIOCIN SODIUM
(1964)
Small molecule
DNA gyrase inhibitor
ORAL
Approved
Unknown
NOVOBIOCIN SODIUM
×
Maximum Phase:
4
First Approval:
1964
UNII:
Q9S9NQ5YIY
Molecule Type:
Small molecule
Molecular Formula:
C31H35N2NaO11
Molecular Weight:
634.61
AlogP:
3.63
PSA:
200.01
HBD:
5.0
HBA:
#RotB:
8.0
Source:
DESIPRAMINE HYDROCHLORIDE
(1964)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depression
DESIPRAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
1Y58DO4MY1
Molecule Type:
Small molecule
Molecular Formula:
C18H23ClN2
Molecular Weight:
302.85
AlogP:
3.53
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ERYTHROMYCIN
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
FOR RX COMPOUNDING; OPHTHALMIC; ORAL; TOPICAL
Approved
Acne Vulgaris; Bacterial Infections; Eye Infections
ERYTHROMYCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
63937KV33D
Molecule Type:
Small molecule
Molecular Formula:
C37H67NO13
Molecular Weight:
733.94
AlogP:
1.79
PSA:
193.91
HBD:
5.0
HBA:
#RotB:
7.0
Source:
VANCOMYCIN
(1964)
Small molecule
Peptidoglycan inhibitor
Unknown
Approved
Bacterial Infections; Diarrhea; Endocarditis; Enterocolitis; Eye Infections; Respiratory Tract Infections; Sepsis; Skin Diseases
VANCOMYCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
6Q205EH1VU
Molecule Type:
Small molecule
Molecular Formula:
C66H75Cl2N9O24
Molecular Weight:
1449.27
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRIAMTERENE
(1964)
Small molecule
Amiloride-sensitive sodium channel, ENaC blocker
ORAL
Approved
Cardiovascular Diseases; Edema; Heart Failure; Hyperaldosteronism; Hypertension; Liver Cirrhosis; Nephrotic Syndrome; Toxemia
TRIAMTERENE
×
Maximum Phase:
4
First Approval:
1964
UNII:
WS821Z52LQ
Molecule Type:
Small molecule
Molecular Formula:
C12H11N7
Molecular Weight:
253.27
AlogP:
0.83
PSA:
129.62
HBD:
3.0
HBA:
#RotB:
1.0
Source:
NOVOBIOCIN
(1964)
Small molecule
Unknown
Unknown
Approved
Unknown
NOVOBIOCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
17EC19951N
Molecule Type:
Small molecule
Molecular Formula:
C31H36N2O11
Molecular Weight:
612.63
AlogP:
3.63
PSA:
200.01
HBD:
5.0
HBA:
#RotB:
8.0
Source:
CYCLOSERINE
(1964)
Small molecule
Alanine racemase inhibitor
ORAL
Approved
Tuberculosis
CYCLOSERINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
95IK5KI84Z
Molecule Type:
Small molecule
Molecular Formula:
C3H6N2O2
Molecular Weight:
102.09
AlogP:
-1.62
PSA:
64.35
HBD:
2.0
HBA:
#RotB:
0.0
Source:
ETHYLESTRENOL
(1964)
Small molecule
Androgen Receptor agonist
ORAL
Approved
Unknown
ETHYLESTRENOL
×
Maximum Phase:
4
First Approval:
1964
UNII:
ADC79EK5Q8
Molecule Type:
Small molecule
Molecular Formula:
C20H32O
Molecular Weight:
288.48
AlogP:
5.09
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ERYTHROMYCIN STEARATE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Unknown
ERYTHROMYCIN STEARATE
×
Maximum Phase:
4
First Approval:
1964
UNII:
LXW024X05M
Molecule Type:
Small molecule
Molecular Formula:
C55H103NO15
Molecular Weight:
1018.42
AlogP:
1.79
PSA:
193.91
HBD:
5.0
HBA:
#RotB:
7.0
Source:
AMPHOTERICIN B
(1964)
Small molecule
Ergosterol sequestering agent
INJECTION; ORAL; TOPICAL
Approved
Aspergillosis; Candidiasis; Cryptococcosis; Histoplasmosis; Infections; Leishmaniasis, Visceral; Meningitis, Cryptococcal; Mucormycosis; Mycoses; Sporotrichosis; Zygomycosis
AMPHOTERICIN B
×
Maximum Phase:
4
First Approval:
1964
UNII:
7XU7A7DROE
Molecule Type:
Small molecule
Molecular Formula:
C47H73NO17
Molecular Weight:
924.09
AlogP:
0.71
PSA:
319.61
HBD:
12.0
HBA:
#RotB:
3.0
Source:
DESIPRAMINE
(1964)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
DESIPRAMINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
TG537D343B
Molecule Type:
Small molecule
Molecular Formula:
C18H22N2
Molecular Weight:
266.39
AlogP:
3.53
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NYSTATIN
(1964)
Small molecule
Ergosterol sequestering agent
ORAL; TOPICAL; VAGINAL
Approved
Candidiasis; Infections
NYSTATIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
BDF1O1C72E
Molecule Type:
Small molecule
Molecular Formula:
C47H75NO17
Molecular Weight:
926.11
AlogP:
0.94
PSA:
319.61
HBD:
12.0
HBA:
#RotB:
3.0
Source:
ERYTHROMYCIN LACTOBIONATE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
INJECTION
Approved
Unknown
ERYTHROMYCIN LACTOBIONATE
×
Maximum Phase:
4
First Approval:
1964
UNII:
33H58I7GLQ
Molecule Type:
Small molecule
Molecular Formula:
C49H89NO25
Molecular Weight:
1092.23
AlogP:
1.79
PSA:
193.91
HBD:
5.0
HBA:
#RotB:
7.0
Source:
OXYTETRACYCLINE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections; Eye Infections
OXYTETRACYCLINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
X20I9EN955
Molecule Type:
Small molecule
Molecular Formula:
C22H24N2O9
Molecular Weight:
460.44
AlogP:
-1.24
PSA:
201.85
HBD:
7.0
HBA:
#RotB:
2.0
Source:
OXYTETRACYCLINE HYDROCHLORIDE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
INJECTION; ORAL
Approved
Unknown
OXYTETRACYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
4U7K4N52ZM
Molecule Type:
Small molecule
Molecular Formula:
C22H25ClN2O9
Molecular Weight:
496.9
AlogP:
-1.24
PSA:
201.85
HBD:
7.0
HBA:
#RotB:
2.0
Source:
NORTRIPTYLINE HYDROCHLORIDE
(1964)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depression
NORTRIPTYLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
00FN6IH15D
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN
Molecular Weight:
299.85
AlogP:
3.83
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
VANCOMYCIN HYDROCHLORIDE
(1964)
Small molecule
Peptidoglycan inhibitor
Unknown
Approved
Endocarditis; Infections
VANCOMYCIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
71WO621TJD
Molecule Type:
Small molecule
Molecular Formula:
C66H76Cl3N9O24
Molecular Weight:
1485.73
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRIOXSALEN
(1964)
Small molecule
DNA inhibitor
ORAL
Approved
Psoriasis
TRIOXSALEN
×
Maximum Phase:
4
First Approval:
1964
UNII:
Y6UY8OV51T
Molecule Type:
Small molecule
Molecular Formula:
C14H12O3
Molecular Weight:
228.25
AlogP:
3.46
PSA:
43.35
HBD:
0.0
HBA:
#RotB:
0.0
Source:
NAFCILLIN SODIUM
(1965)
Small molecule
Penicillin-binding protein inhibitor
INJECTION; ORAL
Approved
Infections
NAFCILLIN SODIUM
×
Maximum Phase:
4
First Approval:
1965
UNII:
49G3001BCK
Molecule Type:
Small molecule
Molecular Formula:
C21H23N2NaO6S
Molecular Weight:
454.48
AlogP:
2.48
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PRILOCAINE HYDROCHLORIDE
(1965)
Small molecule
Sodium channel alpha subunit blocker
INJECTION
Approved
Unknown
PRILOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1965
UNII:
MJW015BAPH
Molecule Type:
Small molecule
Molecular Formula:
C13H21ClN2O
Molecular Weight:
256.78
AlogP:
2.32
PSA:
41.13
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CHLORPHENESIN CARBAMATE
(1965)
Small molecule
Unknown
ORAL
Approved
Unknown
CHLORPHENESIN CARBAMATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
57U5YI11WP
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClNO4
Molecular Weight:
245.66
AlogP:
1.17
PSA:
81.78
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OXAZEPAM
(1965)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
ORAL
Approved
Anxiety; Anxiety Disorders; Mental Disorders
OXAZEPAM
×
Maximum Phase:
4
First Approval:
1965
UNII:
6GOW6DWN2A
Molecule Type:
Small molecule
Molecular Formula:
C15H11ClN2O2
Molecular Weight:
286.72
AlogP:
2.45
PSA:
61.69
HBD:
2.0
HBA:
#RotB:
1.0
Source:
FLURANDRENOLIDE
(1965)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Skin Diseases
FLURANDRENOLIDE
×
Maximum Phase:
4
First Approval:
1965
UNII:
8EUL29XUQT
Molecule Type:
Small molecule
Molecular Formula:
C24H33FO6
Molecular Weight:
436.52
AlogP:
2.5
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
2.0
Source:
1
2
…
10
11
12
13
14
15
16
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA